Suppr超能文献

α-亚麻酸在体外抑制RANKL诱导的破骨细胞生成并在体内预防炎症。

α-Linolenic Acid Inhibits RANKL-Induced Osteoclastogenesis In Vitro and Prevents Inflammation In Vivo.

作者信息

Deng Yufeng, Li Weizhou, Zhang Yingying, Li Jingjing, He Fangting, Dong Ke, Hong Zehui, Luo Ruocheng, Pei Xiaofang

机构信息

West China School of Public Health, West China Fourth Hospital, Sichuan University, Chengdu 610041, China.

Department of Healthcare-Associated Infection Management, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China.

出版信息

Foods. 2023 Feb 3;12(3):682. doi: 10.3390/foods12030682.

Abstract

Inflammation is an important risk factor for bone-destroying diseases. Our preliminary research found that seed oil (ZBSO) is abundant in unsaturated fatty acids and could inhibit osteoclastogenesis in receptor activator of nuclear factor κB ligand (RANKL)-induced RAW264.7 cells. However, the key constituents in ZBSO in the prevention of osteoclastogenesis and its possible mechanism related to inflammation are still unclear. Therefore, in this study, oleic acid (OA), linoleic acid (LA), palmitoleic acid (PLA), and alpha-linolenic acid (ALA) in ZBSO, havingthe strongest effect on RANKL-induced osteoclastogenesis, were selected by a tartrate-resistant acid phosphatase (TRAP) staining method. Furthermore, the effects of the selected fatty acids on anti-inflammation and anti-osteoclastogenesis in vitro and in vivo were assessed using RT-qPCR. Among the four major unsaturated fatty acids we tested, ALA displayed the strongest inhibitory effect on osteoclastogenesis. The increased expression of free fatty acid receptor 4 (FFAR4) and β-arrestin2 (βarr2), as well as the decreased expression of nuclear factor-kappa B (NF-κB), tumor necrosis factor-α (TNF-α), nuclear factor of activated T-cells c1 (NFATc1), and tartrate-resistant acid phosphatase (TRAP) in RAW264.7 cells after ALA treatment were observed. Moreover, in ovariectomized osteoporotic rats with ALA preventive intervention, we found that the expression of TNF-α, interleukin-6 (IL-6), interleukin-1β (IL-1β), NFATc1, and TRAP were decreased, while with the ALA therapeutic intervention, downregulated expression of NF-κB, NFATc1, TRAP, and transforming growth factor beta-activated kinase 1 (TAK1) were noticed. These results indicate that ALA, as the major unsaturated fatty acid in ZBSO, could inhibit RANKL-induced osteoclastogenesis via the FFAR4/βarr2 signaling pathway and could prevent inflammation, suggesting that ZBSO may be a promising potential natural product of unsaturated fatty acids and a dietary supplement for the prevention of osteoclastogenesis and inflammatory diseases.

摘要

炎症是导致骨质破坏疾病的一个重要风险因素。我们的初步研究发现,籽实油(ZBSO)富含不饱和脂肪酸,并且能够抑制核因子κB受体活化因子配体(RANKL)诱导的RAW264.7细胞的破骨细胞生成。然而,ZBSO中预防破骨细胞生成的关键成分及其与炎症相关的可能机制仍不清楚。因此,在本研究中,通过抗酒石酸酸性磷酸酶(TRAP)染色法,从ZBSO中筛选出对RANKL诱导的破骨细胞生成影响最强的油酸(OA)、亚油酸(LA)、棕榈油酸(PLA)和α-亚麻酸(ALA)。此外,使用RT-qPCR评估所选脂肪酸在体外和体内的抗炎和抗破骨细胞生成作用。在我们测试的四种主要不饱和脂肪酸中,ALA对破骨细胞生成的抑制作用最强。观察到ALA处理后RAW264.7细胞中游离脂肪酸受体4(FFAR4)和β-抑制蛋白2(βarr2)的表达增加,以及核因子-κB(NF-κB)、肿瘤坏死因子-α(TNF-α)、活化T细胞核因子c1(NFATc1)和抗酒石酸酸性磷酸酶(TRAP)的表达降低。此外,在接受ALA预防性干预的去卵巢骨质疏松大鼠中,我们发现TNF-α、白细胞介素-6(IL-6)、白细胞介素-1β(IL-1β)、NFATc1和TRAP的表达降低,而在接受ALA治疗性干预时,观察到NF-κB、NFATc1、TRAP和转化生长因子β激活激酶1(TAK1)的表达下调。这些结果表明,作为ZBSO中的主要不饱和脂肪酸,ALA可通过FFAR4/βarr2信号通路抑制RANKL诱导的破骨细胞生成,并可预防炎症,这表明ZBSO可能是一种有前景的潜在不饱和脂肪酸天然产物和预防破骨细胞生成及炎症性疾病的膳食补充剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b1b/9914290/11164dd6e6d7/foods-12-00682-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验